The Australian general practice landscape is changing and so should pharma’s playbook. For years, pharmaceutical companies have focused their energy on reaching doctors. But the real gatekeepers of access, time, and influence increasingly sit just outside the consulting rooms: Practice Managers.
They may not prescribe drugs, but they decide who gets in the door, when, and on what terms. In a system under pressure, that power is only growing.
Read more
AusDoc is expanding beyond its core doctor audience to include primary care nurses through a strategic partnership with the Australian Primary Health Nurse Association (APNA).
Read more
ADHD is no longer peripheral to Australian general practice. Rising patient demand, prolonged specialist wait times, and growing public awareness mean GPs are now central to ongoing ADHD care.
For pharmaceutical companies, this creates a clear opportunity, but also exposes the limits of traditional engagement models.
Read more
Doctors were clear that pharma delivers substantial scientific progress but equally clear that trust hasn’t kept pace. Addressing this gap between high innovation and low trust is exactly where the opportunity lies to reset the doctor–pharma relationship.
Read more
Missed the webinar? You can still hear the full and uncensored debrief of what over 1,000 Australian doctors revealed in the AusDoc Big Doctor Survey
From Australia’s #1 platform for doctors, AusDoc.
Download the webinar recording and slides.
Read more
NEXT Pharma Summit Australia is coming to Sydney on October 22–23, 2025
Australia’s #1 platform for doctors, AusDoc brings the voice of the doctor into the conversation, shaping the future of pharma and healthcare in Australia.
Use promo code ‘ausdoc’ for 10% earlybird discount.
Read more
Our latest GP survey reveals clear patterns in how Australian doctors are managing menopause with some therapies dominating and others barely used.
The findings highlight important opportunities for pharma to support doctors’ decision-making and improve patient care.
Read more
Most Australian GPs encounter rare disease patients without the knowledge or tools to act quickly. AusDoc survey data reveals exactly where the confidence gaps are — and why pharma has a significant and largely untapped opportunity to step in with targeted GP education.
Read more
AusDoc has been confirmed as the #1 medical publication for Australian GPs in the 2025 annual readership survey — ranked first across print, digital and newsletters. The results reinforce AusDoc’s unmatched reach for any pharma or health brand looking to engage Australian doctors.
Read more
Australian Doctor has been shortlisted for one of the most prestigious accolades in the publishing industry — Publication of the Year — at the 2025 Mumbrella Publish Awards.
Read more